1. Home
  2. ALRS vs CTMX Comparison

ALRS vs CTMX Comparison

Compare ALRS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALRS
  • CTMX
  • Stock Information
  • Founded
  • ALRS 1879
  • CTMX 2008
  • Country
  • ALRS United States
  • CTMX United States
  • Employees
  • ALRS N/A
  • CTMX N/A
  • Industry
  • ALRS Major Banks
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALRS Finance
  • CTMX Health Care
  • Exchange
  • ALRS Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • ALRS 536.4M
  • CTMX 596.2M
  • IPO Year
  • ALRS 2019
  • CTMX 2015
  • Fundamental
  • Price
  • ALRS $21.29
  • CTMX $4.21
  • Analyst Decision
  • ALRS Hold
  • CTMX Strong Buy
  • Analyst Count
  • ALRS 4
  • CTMX 5
  • Target Price
  • ALRS $25.00
  • CTMX $5.80
  • AVG Volume (30 Days)
  • ALRS 67.8K
  • CTMX 3.3M
  • Earning Date
  • ALRS 10-30-2025
  • CTMX 11-06-2025
  • Dividend Yield
  • ALRS 4.01%
  • CTMX N/A
  • EPS Growth
  • ALRS 1114.48
  • CTMX 263.20
  • EPS
  • ALRS 1.95
  • CTMX 0.49
  • Revenue
  • ALRS $275,452,000.00
  • CTMX $141,100,000.00
  • Revenue This Year
  • ALRS $43.14
  • CTMX N/A
  • Revenue Next Year
  • ALRS $2.95
  • CTMX N/A
  • P/E Ratio
  • ALRS $10.89
  • CTMX $8.61
  • Revenue Growth
  • ALRS 67.44
  • CTMX 18.01
  • 52 Week Low
  • ALRS $15.78
  • CTMX $0.40
  • 52 Week High
  • ALRS $24.33
  • CTMX $4.46
  • Technical
  • Relative Strength Index (RSI)
  • ALRS 46.78
  • CTMX 73.96
  • Support Level
  • ALRS $20.31
  • CTMX $3.22
  • Resistance Level
  • ALRS $21.63
  • CTMX $3.50
  • Average True Range (ATR)
  • ALRS 0.47
  • CTMX 0.31
  • MACD
  • ALRS 0.01
  • CTMX 0.05
  • Stochastic Oscillator
  • ALRS 62.42
  • CTMX 80.93

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: